Detalhe da pesquisa
1.
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody.
Cell
; 185(8): 1389-1401.e18, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344711
2.
Antivirals with common targets against highly pathogenic viruses.
Cell
; 184(6): 1604-1620, 2021 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740455
3.
Inhibition of viral suppressor of RNAi proteins by designer peptides protects from enteroviral infection in vivo.
Immunity
; 54(10): 2231-2244.e6, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34555337
4.
SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequences.
Trends Immunol
; 45(2): 81-84, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38302341
5.
High-throughput screening of mutations affecting SARS-CoV-2 spike functions.
Trends Immunol
; 44(5): 321-323, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37031063
6.
A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates.
Proc Natl Acad Sci U S A
; 120(11): e2221713120, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897979
7.
Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants.
Proc Natl Acad Sci U S A
; 120(17): e2300376120, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068258
8.
Developing pan-ß-coronavirus vaccines against emerging SARS-CoV-2 variants of concern.
Trends Immunol
; 43(3): 170-172, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35125310
9.
A subunit-based influenza/SARS-CoV-2 Omicron combined vaccine induced potent protective immunity in BALB/c mice.
J Med Virol
; 96(3): e29479, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425270
10.
Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies.
Bioorg Med Chem Lett
; 97: 129569, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008340
11.
Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history.
BMC Biol
; 21(1): 205, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37784185
12.
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant.
Clin Microbiol Rev
; 35(3): e0001422, 2022 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35862736
13.
Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein.
J Virol
; 96(24): e0124522, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36468859
14.
Pan-coronavirus fusion inhibitors to combat COVID-19 and other emerging coronavirus infectious diseases.
J Med Virol
; 95(1): e28143, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36098460
15.
25-hydroxycholesterol inhibits human papillomavirus infection in cervical epithelial cells by perturbing cytoskeletal remodeling.
J Med Virol
; 95(6): e28834, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254637
16.
Development of variant-proof severe acute respiratory syndrome coronavirus 2, pan-sarbecovirus, and pan-ß-coronavirus vaccines.
J Med Virol
; 95(1): e28172, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36161303
17.
SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors.
J Med Virol
; 95(3): e28641, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36890632
18.
Repurposing Navitoclax to block SARS-CoV-2 fusion and entry by targeting heptapeptide repeat sequence 1 in S2 protein.
J Med Virol
; 95(10): e29145, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804480
19.
Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: Implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies.
J Med Virol
; 95(2): e28440, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36573441
20.
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.
Trends Immunol
; 41(5): 355-359, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32249063